Complete Tumor Regression

Direct activation of STING in the tumor microenvironment partially overcomes immune tolerance in neu-N transgenic mice
Jeremy Foote, James M Leatherman, Todd D Amstrong, Laureen Ojalvo, David Kanne, Elizabeth M Jaffee, Tom Dubensky, Leisha Emens

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P356; DOI: 10.1186/2051-1426-3-S2-P356
Adoptively transferred tumor-infiltrating T cells target somatic cancer mutations in a human papillomavirus+ cancer patient with complete tumor regression
Sanja Stevanović, Pasetto Anna, Jared J Gartner, Eric Tran, Paul F Robbins, Steven A Rosenberg, Christian S Hinrichs

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P52; DOI: 10.1186/2051-1426-3-S2-P52
Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
Zuzana Berrong, Shamim Ahmad, Rasha Abu Eid, Abdeljabar El Andaloussi, Tanusree Sen, Ross Stewart, Scott A Hammond, Rajeev Shrimali, Mikayel Mkrtichyan, Samir N Khleif

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P226; DOI: 10.1186/2051-1426-2-S3-P226

Main menu